BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30327548)

  • 1. Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.
    Sarkar S; Poon CC; Mirzaei R; Rawji KS; Hader W; Bose P; Kelly J; Dunn JF; Yong VW
    Sci Rep; 2018 Oct; 8(1):15286. PubMed ID: 30327548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
    Sarkar S; Zemp FJ; Senger D; Robbins SM; Yong VW
    Neuro Oncol; 2015 Aug; 17(8):1095-105. PubMed ID: 25646025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
    Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
    Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBM secretome induces transient transformation of human neural precursor cells.
    Venugopal C; Wang XS; Manoranjan B; McFarlane N; Nolte S; Li M; Murty N; Siu KW; Singh SK
    J Neurooncol; 2012 Sep; 109(3):457-66. PubMed ID: 22752853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
    Choi SA; Lee JY; Kwon SE; Wang KC; Phi JH; Choi JW; Jin X; Lim JY; Kim H; Kim SK
    PLoS One; 2015; 10(6):e0129292. PubMed ID: 26076490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation.
    Wurdak H; Zhu S; Romero A; Lorger M; Watson J; Chiang CY; Zhang J; Natu VS; Lairson LL; Walker JR; Trussell CM; Harsh GR; Vogel H; Felding-Habermann B; Orth AP; Miraglia LJ; Rines DR; Skirboll SL; Schultz PG
    Cell Stem Cell; 2010 Jan; 6(1):37-47. PubMed ID: 20085741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53.
    Fukaya R; Ohta S; Yaguchi T; Matsuzaki Y; Sugihara E; Okano H; Saya H; Kawakami Y; Kawase T; Yoshida K; Toda M
    Cancer Res; 2016 May; 76(9):2813-23. PubMed ID: 26980763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of murine xenograft models of brain tumors from primary human tissue for in vivo analysis of the brain tumor-initiating cell.
    Qazi M; Mann A; van Ommeren R; Venugopal C; McFarlane N; Vora P; Singh SK
    Methods Mol Biol; 2014; 1210():37-49. PubMed ID: 25173159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.
    Wang X; Huang Z; Wu Q; Prager BC; Mack SC; Yang K; Kim LJY; Gimple RC; Shi Y; Lai S; Xie Q; Miller TE; Hubert CG; Song A; Dong Z; Zhou W; Fang X; Zhu Z; Mahadev V; Bao S; Rich JN
    Cancer Res; 2017 Sep; 77(18):4947-4960. PubMed ID: 28729418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.
    Chokshi C; Dhillon M; McFarlane N; Venugopal C; Singh SK
    Methods Mol Biol; 2016; 1458():231-45. PubMed ID: 27581026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.
    Xie Q; Wu Q; Kim L; Miller TE; Liau BB; Mack SC; Yang K; Factor DC; Fang X; Huang Z; Zhou W; Alazem K; Wang X; Bernstein BE; Bao S; Rich JN
    J Clin Invest; 2016 Jul; 126(7):2757-72. PubMed ID: 27322055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes.
    Sarkar S; Li Y; Mirzaei R; Rawji KS; Poon CC; Wang J; Kumar M; Bose P; Yong VW
    Front Immunol; 2020; 11():272. PubMed ID: 32153581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.
    Sarkar S; Döring A; Zemp FJ; Silva C; Lun X; Wang X; Kelly J; Hader W; Hamilton M; Mercier P; Dunn JF; Kinniburgh D; van Rooijen N; Robbins S; Forsyth P; Cairncross G; Weiss S; Yong VW
    Nat Neurosci; 2014 Jan; 17(1):46-55. PubMed ID: 24316889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells.
    Dzikowski L; Mirzaei R; Sarkar S; Kumar M; Bose P; Bellail A; Hao C; Yong VW
    Brain Pathol; 2021 Sep; 31(5):e12947. PubMed ID: 33694259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth arrest-specific protein 1 is a novel endogenous inhibitor of glomerular cell activation and proliferation.
    van Roeyen CR; Zok S; Pruessmeyer J; Boor P; Nagayama Y; Fleckenstein S; Cohen CD; Eitner F; Gröne HJ; Ostendorf T; Ludwig A; Floege J
    Kidney Int; 2013 Feb; 83(2):251-63. PubMed ID: 23254899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells.
    Seliger C; Rauer L; Wüster AL; Moeckel S; Leidgens V; Jachnik B; Ammer LM; Heckscher S; Dettmer K; Riemenschneider MJ; Oefner PJ; Proescholdt M; Vollmann-Zwerenz A; Hau P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.
    Yu D; Khan OF; Suvà ML; Dong B; Panek WK; Xiao T; Wu M; Han Y; Ahmed AU; Balyasnikova IV; Zhang HF; Sun C; Langer R; Anderson DG; Lesniak MS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6147-E6156. PubMed ID: 28696296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.